MP Healthcare Venture Management
Home About Us Portfolio News Contact
HomeAbout UsPortfolioNewsContact
MP Healthcare Venture Management
QurAlis raises $42 Million Series A Financing to Develop New Therapies for Amyotrophic Lateral Sclerosis (ALS)
Guest UserMay 13, 2020
Facebook0 Twitter LinkedIn0 Reddit 0 Likes
Previous

Sonde Health Launches New Voice-Enabled Health Screening Tool to Help Employers Return to Work During the Global Pandemic

Guest UserJuly 8, 2020
Next

FORGE ENTERS INTO COLLABORATION WITH ROCHE TO DEVELOP NOVEL ANTIBIOTIC TO TREAT LUNG INFECTIONS

Guest UserMarch 25, 2020

© 2010-2025 MP Healthcare Venture Management, Inc.
All Rights Reserved.

Privacy Policy | Terms of Use

About UsPortfolioNews Contact